Trial intelligence / Profile preview

ESPB vs Opioid GA in Bariatric Surgery

NCT03798522Completed

Sponsor
Cairo University
Start
Feb 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain, sponsored by Cairo University. Primary endpoint: Duration of analgesic effect at 8 hours. Started Feb 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03798522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03798522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call